{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:52:37Z","timestamp":1791067957377,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"DOI":"10.1007\/s11926-026-01238-8","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:48:45Z","timestamp":1791020925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seronegative Immune-Mediated Necrotizing Myopathy: An Overview for Optimal Clinical Management"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4338-4879","authenticated-orcid":false,"given":"Dimitris C.","family":"Kounatidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dalamaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Zoubouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Tsaroucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Konsta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia G.","family":"Vallianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"issue":"12","key":"1238_CR1","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41584-020-00515-9","volume":"16","author":"Y Allenbach","year":"2020","unstructured":"Allenbach Y, Benveniste O, Stenzel W, Boyer O. Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol. 2020;16(12):689\u2013701. https:\/\/doi.org\/10.1038\/s41584-020-00515-9.","journal-title":"Nat Rev Rheumatol"},{"issue":"19","key":"1238_CR2","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJMra2415426","volume":"394","author":"Y Allenbach","year":"2026","unstructured":"Allenbach Y, Benveniste O, Inflammatory Myopathies. N Engl J Med. 2026;394(19):1925\u201338. https:\/\/doi.org\/10.1056\/NEJMra2415426.","journal-title":"N Engl J Med"},{"issue":"6","key":"1238_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/BOR.0000000000000335","volume":"28","author":"I Pinal-Fernandez","year":"2016","unstructured":"Pinal-Fernandez I, Mammen AL. Spectrum of immune-mediated necrotizing myopathies and their treatments. Curr Opin Rheumatol. 2016;28(6):619\u201324. https:\/\/doi.org\/10.1097\/BOR.0000000000000335.","journal-title":"Curr Opin Rheumatol"},{"key":"1238_CR4","doi-asserted-by":"publisher","first-page":"103286","DOI":"10.1016\/j.jaut.2024.103286","volume":"148","author":"C Li","year":"2024","unstructured":"Li C, Liu H, Yang L, Liu R, Yin G, Xie Q. Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments. J Autoimmun. 2024;148:103286. https:\/\/doi.org\/10.1016\/j.jaut.2024.103286.","journal-title":"J Autoimmun"},{"issue":"1","key":"1238_CR5","doi-asserted-by":"publisher","first-page":"34884","DOI":"10.1038\/s41598-025-17766-9","volume":"15","author":"Y Cao","year":"2025","unstructured":"Cao Y, Li W, He X, Liao M, Hu K, Wu S, Zhang X, Liao Q, Shen Z, Liang Z, Zheng C, Zhong Z, Jiang H, Huang Q, Zheng H. Clinical-pathologic classification of anti-HMGCR-positive immune-mediated necrotizing myopathy. Sci Rep. 2025;15(1):34884. https:\/\/doi.org\/10.1038\/s41598-025-17766-9.","journal-title":"Sci Rep"},{"issue":"6","key":"1238_CR6","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/BOR.0000000000000832","volume":"33","author":"T Kurashige","year":"2021","unstructured":"Kurashige T. Anti-HMGCR myopathy: clinical and histopathological features, and prognosis. Curr Opin Rheumatol. 2021;33(6):554\u201362. https:\/\/doi.org\/10.1097\/BOR.0000000000000832.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"1238_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/rheumatology\/keac144","volume":"62","author":"S Shelly","year":"2022","unstructured":"Shelly S, Beecher G, Milone M, Liewluck T, Ernste F, Triplett J, Naddaf E, Zekeridou A, McKeon A, Pittock SJ, Dubey D, Mills JR, Mandrekar J, Klein CJ. Cancer and immune-mediated necrotizing myopathy: a longitudinal referral case-controlled outcomes evaluation. Rheumatology (Oxford). 2022;62(1):281\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/keac144.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1238_CR8","doi-asserted-by":"publisher","first-page":"e513","DOI":"10.1212\/NXI.0000000000000513","volume":"6","author":"J Lim","year":"2018","unstructured":"Lim J, Rietveld A, De Bleecker JL, Badrising UA, Saris CGJ, van der Kooi AJ, de Visser M. Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy. Neurol Neuroimmunol Neuroinflamm. 2018;6(1):e513. https:\/\/doi.org\/10.1212\/NXI.0000000000000513.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1238_CR9","doi-asserted-by":"publisher","first-page":"670784","DOI":"10.3389\/fneur.2021.670784","volume":"12","author":"X Ma","year":"2021","unstructured":"Ma X, Xu L, Ji S, Li Y, Bu B. The Clinicopathological Distinction Between Seropositive and Seronegative Immune-Mediated Necrotizing Myopathy in China. Front Neurol. 2021;12:670784. https:\/\/doi.org\/10.3389\/fneur.2021.670784.","journal-title":"Front Neurol"},{"issue":"10","key":"1238_CR10","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.mayocp.2020.03.032","volume":"95","author":"J Triplett","year":"2020","unstructured":"Triplett J, Kassardjian CD, Liewluck T, Tahir A, Lennon V, Kopecky S, Milone M. Cardiac and Respiratory Complications of Necrotizing Autoimmune Myopathy. Mayo Clin Proc. 2020;95(10):2144\u20139. https:\/\/doi.org\/10.1016\/j.mayocp.2020.03.032.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"1238_CR11","doi-asserted-by":"publisher","first-page":"e63394","DOI":"10.7759\/cureus.63394","volume":"16","author":"M Kumar","year":"2024","unstructured":"Kumar M, Ali SM, Kumar V, Alsibai A, Parkash O. Steroid-Responsive Seronegative Immune-Mediated Necrotizing Myopathy Likely Triggered by Coxsackie B Virus: A Case Report. Cureus. 2024;16(6):e63394. https:\/\/doi.org\/10.7759\/cureus.63394.","journal-title":"Cureus"},{"issue":"3","key":"1238_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/CND.0000000000000431","volume":"24","author":"CH Chang","year":"2023","unstructured":"Chang CH, Gupta R, Setyono D, Cuevas-Ocampo AK, Khoshnoodi MA. Refractory Seronegative Immune-Mediated Necrotizing Myopathy After Receiving mRNA-1273 SARS-CoV-2 Vaccine: A Case Report. J Clin Neuromuscul Dis. 2023;24(3):168\u20139. https:\/\/doi.org\/10.1097\/CND.0000000000000431.","journal-title":"J Clin Neuromuscul Dis"},{"key":"1238_CR13","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3389\/fneur.2018.01028","volume":"9","author":"Y Li","year":"2018","unstructured":"Li Y, Meng L, Yuan Y, Meng L, Lin J, Bu B. Severe Recurrent Necrotizing Myopathy in Pregnancy: A Case Report. Front Neurol. 2018;9:1028. https:\/\/doi.org\/10.3389\/fneur.2018.01028.","journal-title":"Front Neurol"},{"issue":"8","key":"1238_CR14","doi-asserted-by":"publisher","first-page":"e27824","DOI":"10.7759\/cureus.27824","volume":"14","author":"S Patel","year":"2022","unstructured":"Patel S, Abu-Abaa M, Mousavi F. Seronegative Immune-Mediated Necrotizing Myopathy: A Case Report. Cureus. 2022;14(8):e27824. https:\/\/doi.org\/10.7759\/cureus.27824.","journal-title":"Cureus"},{"issue":"Pt 8","key":"1238_CR15","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/brain\/aww054","volume":"139","author":"Y Allenbach","year":"2016","unstructured":"Allenbach Y, Keraen J, Bouvier AM, Jooste V, Champtiaux N, Hervier B, Schoindre Y, Rigolet A, Gilardin L, Musset L, Charuel JL, Boyer O, Jouen F, Drouot L, Martinet J, Stojkovic T, Eymard B, Lafor\u00eat P, Behin A, Salort-Campana E, Fain O, Meyer A, Schleinitz N, Mariampillai K, Grados A, Benveniste O. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. Brain. 2016;139(Pt 8):2131\u20135. https:\/\/doi.org\/10.1093\/brain\/aww054.","journal-title":"Brain"},{"issue":"1","key":"1238_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","volume":"28","author":"Y Allenbach","year":"2018","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W, Immune-Mediated Necrotizing Myopathies Working Group. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016. Neuromuscul Disord. 2018;28(1):87\u201399. https:\/\/doi.org\/10.1016\/j.nmd.2017.09.016.","journal-title":"Neuromuscul Disord"},{"issue":"8","key":"1238_CR17","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1093\/rheumatology\/keab900","volume":"61","author":"A Lia","year":"2022","unstructured":"Lia A, Annese T, Fornaro M, Giannini M, D\u2019Abbicco D, Errede M, Lorusso L, Amati A, Tampoia M, Trojano M, Virgintino D, Ribatti D, Serlenga L, Iannone F, Girolamo F. Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy. Rheumatology (Oxford). 2022;61(8):3448\u201360. https:\/\/doi.org\/10.1093\/rheumatology\/keab900.","journal-title":"Rheumatology (Oxford)"},{"key":"1238_CR18","doi-asserted-by":"publisher","first-page":"585108","DOI":"10.3389\/fimmu.2020.585108","volume":"11","author":"SR Barnum","year":"2020","unstructured":"Barnum SR, Bubeck D, Schein TN. Soluble Membrane Attack Complex: Biochemistry and Immunobiology. Front Immunol. 2020;11:585108. https:\/\/doi.org\/10.3389\/fimmu.2020.585108.","journal-title":"Front Immunol"},{"issue":"5","key":"1238_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/tan.14950","volume":"101","author":"Y Ohnuki","year":"2023","unstructured":"Ohnuki Y, Suzuki S, Uruha A, Oyama M, Suzuki S, Kulski JK, Nishino I, Shiina T. Association of immune-mediated necrotizing myopathy with HLA polymorphisms. HLA. 2023;101(5):449\u201357. https:\/\/doi.org\/10.1111\/tan.14950.","journal-title":"HLA"},{"issue":"1","key":"1238_CR20","doi-asserted-by":"publisher","first-page":"e3598","DOI":"10.1002\/jgm.3598","volume":"26","author":"H Liu","year":"2024","unstructured":"Liu H, Deng L, Guo Y, Liu H, Chen B, Zhang J, Ran J, Yin G, Xie Q. Comprehensive transcriptomic analysis and machine learning reveal unique gene expression profiles in patients with immune-mediated necrotizing myopathy. J Gene Med. 2024;26(1):e3598. https:\/\/doi.org\/10.1002\/jgm.3598.","journal-title":"J Gene Med"},{"issue":"11","key":"1238_CR21","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.3390\/diagnostics11112064","volume":"11","author":"S Park","year":"2021","unstructured":"Park S, Jang DH, Kim JM, Yoon N. Prominent Asymmetric Muscle Weakness and Atrophy in Seronegative Immune-Mediated Necrotizing Myopathy. Diagnostics (Basel). 2021;11(11):2064. https:\/\/doi.org\/10.3390\/diagnostics11112064.","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"1238_CR22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.semarthrit.2019.04.002","volume":"49","author":"JA Day","year":"2019","unstructured":"Day JA, Limaye V. Immune-mediated necrotising myopathy: A critical review of current concepts. Semin Arthritis Rheum. 2019;49(3):420\u20139. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.04.002.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"1238_CR23","doi-asserted-by":"publisher","first-page":"e81018","DOI":"10.7759\/cureus.81018","volume":"17","author":"N Takaku","year":"2025","unstructured":"Takaku N, Hayashi K, Suzuki A, Nakaya Y, Sato M, Miura T, Nishino I, Kobayashi Y. Dysphagia During Pharyngeal and Esophageal Phase of Seronegative Immune-Mediated Necrotizing Myopathy: A Case Report. Cureus. 2025;17(3):e81018. https:\/\/doi.org\/10.7759\/cureus.81018.","journal-title":"Cureus"},{"key":"1238_CR24","doi-asserted-by":"publisher","first-page":"1094611","DOI":"10.3389\/fimmu.2023.1094611","volume":"14","author":"M Liu","year":"2023","unstructured":"Liu M, Lin Y, Qiao L, Chen J, Shi Q. Characteristics of cardiac involvement in immune-mediated necrotizing myopathy. Front Immunol. 2023;14:1094611. https:\/\/doi.org\/10.3389\/fimmu.2023.1094611.","journal-title":"Front Immunol"},{"key":"1238_CR25","doi-asserted-by":"publisher","first-page":"e951603","DOI":"10.12659\/AJCR.951603","volume":"27","author":"BD Lueck","year":"2026","unstructured":"Lueck BD, Maclean AKW, El Hasbani G, Layman AJ, Ernste FC, Arment CA. Fatal Cardiomyopathy Secondary to Seronegative Immune-Mediated Necrotizing Myopathy: A Case Report. Am J Case Rep. 2026;27:e951603. https:\/\/doi.org\/10.12659\/AJCR.951603.","journal-title":"Am J Case Rep"},{"issue":"4","key":"1238_CR26","doi-asserted-by":"publisher","first-page":"e248535","DOI":"10.1136\/bcr-2021-248535","volume":"15","author":"D Tsang","year":"2022","unstructured":"Tsang D, Malladi CL, Patel K, Bajaj P. Seronegative immune-mediated necrotising myopathy complicated by fulminant myocarditis resulting in cardiogenic shock and cardiac arrest. BMJ Case Rep. 2022;15(4):e248535. https:\/\/doi.org\/10.1136\/bcr-2021-248535.","journal-title":"BMJ Case Rep"},{"issue":"7","key":"1238_CR27","doi-asserted-by":"publisher","first-page":"ytaf313","DOI":"10.1093\/ehjcr\/ytaf313","volume":"9","author":"J Bienz","year":"2025","unstructured":"Bienz J, Meister TA, Soria R, Boscolo Berto M, Rexhaj E. Pickering syndrome facilitated by seronegative immune mediated necrotizing myopathy: a case report. Eur Heart J Case Rep. 2025;9(7):ytaf313. https:\/\/doi.org\/10.1093\/ehjcr\/ytaf313.","journal-title":"Eur Heart J Case Rep"},{"issue":"11","key":"1238_CR28","doi-asserted-by":"publisher","first-page":"e236603","DOI":"10.1136\/bcr-2020-236603","volume":"13","author":"S Glenn-Cox","year":"2020","unstructured":"Glenn-Cox S, Foley RW, Pauling JD, Rodrigues JCL. Fulminant immune-mediated necrotising myopathy (IMNM) mimicking myocardial infarction with non-obstructive coronary arteries (MINOCA). BMJ Case Rep. 2020;13(11):e236603. https:\/\/doi.org\/10.1136\/bcr-2020-236603.","journal-title":"BMJ Case Rep"},{"issue":"6","key":"1238_CR29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.anpede.2020.10.009","volume":"95","author":"L Mart\u00edn Pedraz","year":"2021","unstructured":"Mart\u00edn Pedraz L, Galindo Zavala R, Yun Castilla C, Ortiz Garrido A, N\u00fa\u00f1ez Cuadros E. Seronegative immune-mediated necrotising myopathy with myocardial involvement. Pediatr (Engl Ed). 2021;95(6):470\u20132. https:\/\/doi.org\/10.1016\/j.anpede.2020.10.009.","journal-title":"Pediatr (Engl Ed)"},{"issue":"5","key":"1238_CR30","doi-asserted-by":"publisher","first-page":"e70931","DOI":"10.1002\/cns.70931","volume":"32","author":"C Gao","year":"2026","unstructured":"Gao C, Li W, Liu Q, Wang G, Peng Q. Etiopathogenesis of Immune-Mediated Necrotizing Myopathy: A Comprehensive Review of Recent Advances. CNS Neurosci Ther. 2026;32(5):e70931. https:\/\/doi.org\/10.1002\/cns.70931.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"1238_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/antib13010012","volume":"13","author":"S Julien","year":"2024","unstructured":"Julien S, Challier I, Malleter M, Jouen F, Drouot L, Boyer O. Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies. Antibodies (Basel). 2024;13(1):12. https:\/\/doi.org\/10.3390\/antib13010012.","journal-title":"Antibodies (Basel)"},{"issue":"9","key":"1238_CR32","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/art.27572","volume":"62","author":"L Christopher-Stine","year":"2010","unstructured":"Christopher-Stine L, Casciola-Rosen LA, Hong G, Chung T, Corse AM, Mammen AL. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum. 2010;62(9):2757\u201366. https:\/\/doi.org\/10.1002\/art.27572.","journal-title":"Arthritis Rheum"},{"key":"1238_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s41927-020-00128-5","volume":"4","author":"R Thomas","year":"2020","unstructured":"Thomas R, Yeoh SA, Berkeley R, Woods A, Stevens M, Marino S, Radunovic A. Initial seronegative immune-mediated necrotising myopathy with subsequent anti-HMGCR antibody development and response to rituximab: case report. BMC Rheumatol. 2020;4:29. https:\/\/doi.org\/10.1186\/s41927-020-00128-5.","journal-title":"BMC Rheumatol"},{"issue":"4","key":"1238_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11926-018-0732-6","volume":"20","author":"I Pinal-Fernandez","year":"2018","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-Mediated Necrotizing Myopathy. Curr Rheumatol Rep. 2018;20(4):21. https:\/\/doi.org\/10.1007\/s11926-018-0732-6.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"1238_CR35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12891-022-05372-z","volume":"23","author":"H Yang","year":"2022","unstructured":"Yang H, Tian X, Zhang L, Li W, Liu Q, Jiang W, Peng Q, Wang G, Lu X. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort. BMC Musculoskelet Disord. 2022;23(1):425. https:\/\/doi.org\/10.1186\/s12891-022-05372-z.","journal-title":"BMC Musculoskelet Disord"},{"issue":"4","key":"1238_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/08998280.2021.1885091","volume":"34","author":"R Liu","year":"2021","unstructured":"Liu R, Fenves AZ, Champion SN, Dau J. Seronegative necrotizing autoimmune myopathy with favorable response to intravenous immunoglobulin. Proc (Bayl Univ Med Cent). 2021;34(4):481\u20133. https:\/\/doi.org\/10.1080\/08998280.2021.1885091.","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"5","key":"1238_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/mus.27504","volume":"65","author":"S Shelly","year":"2022","unstructured":"Shelly S, Mielke MM, Paul P, Milone M, Tracy JA, Mills JR, Klein CJ, Ernste FC, Mandrekar J, Liewluck T. Incidence and prevalence of immune-mediated necrotizing myopathy in adults in Olmsted County, Minnesota. Muscle Nerve. 2022;65(5):541\u20136. https:\/\/doi.org\/10.1002\/mus.27504.","journal-title":"Muscle Nerve"},{"key":"1238_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/ncn3.12781","volume":"12","author":"Y Hayashi","year":"2024","unstructured":"Hayashi Y, Ozono T, Beck G, et al. Successful treatment of seronegative immune-mediated necrotizing myopathy developing during pregnancy: A case report and literature review. Neurol Clin Neurosci. 2024;12:113\u20137. https:\/\/doi.org\/10.1111\/ncn3.12781.","journal-title":"Neurol Clin Neurosci"},{"issue":"6","key":"1238_CR39","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/BOR.0000000000000836","volume":"33","author":"A Selva-O\u2019Callaghan","year":"2021","unstructured":"Selva-O\u2019Callaghan A, Trallero-Aragu\u00e1s E, Milisenda JC, Grau-Junyent JM. Differential diagnosis of necrotizing myopathy. Curr Opin Rheumatol. 2021;33(6):544\u201353. https:\/\/doi.org\/10.1097\/BOR.0000000000000836.","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"1238_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/injr.injr_136_20","volume":"15","author":"JD Pauling","year":"2020","unstructured":"Pauling JD, Skeoch S, Paik JJ. The clinicoserological spectrum of inflammatory myopathy in the context of systemic sclerosis and systemic lupus erythematosus. Indian J Rheumatol. 2020;15(6):81\u201390. https:\/\/doi.org\/10.4103\/injr.injr_136_20.","journal-title":"Indian J Rheumatol"},{"issue":"1","key":"1238_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/antib13010012","volume":"13","author":"S Julien","year":"2024","unstructured":"Julien S, Challier I, Malleter M, Jouen F, Drouot L, Boyer O. Immune-Mediated Necrotizing Myopathy (IMNM): A Story of Antibodies. Antibodies (Basel). 2024;13(1):12. https:\/\/doi.org\/10.3390\/antib13010012.","journal-title":"Antibodies (Basel)"},{"issue":"2","key":"1238_CR42","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/acn3.51973","volume":"11","author":"T Kazuta","year":"2024","unstructured":"Kazuta T, Murakami A, Noda S, Hirano S, Kito H, Tsujikawa K, Nakanishi H, Kimura S, Sahashi K, Koike H, Katsuno M. Clinicopathological features of graft versus host disease-associated myositis. Ann Clin Transl Neurol. 2024;11(2):508\u201319. https:\/\/doi.org\/10.1002\/acn3.51973.","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"1238_CR43","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/ajh.27294","volume":"99","author":"A Bourhis","year":"2024","unstructured":"Bourhis A, Robin M, Nguyen S, Uguen A, Hemon P, Dhedin N, Maisonobe T, de Masson A, Benveniste O, Soci\u00e9 G, de La Peffault R, Leonard-Louis S, Hervier B. Myopathy related to chronic Graft-Versus-Host Disease: From clinic to histological & immunological characterization by imaging mass cytometry. Am J Hematol. 2024;99(6):1187\u201391. https:\/\/doi.org\/10.1002\/ajh.27294.","journal-title":"Am J Hematol"},{"issue":"2","key":"1238_CR44","doi-asserted-by":"publisher","first-page":"fcaa181","DOI":"10.1093\/braincomms\/fcaa181","volume":"2","author":"S Shelly","year":"2020","unstructured":"Shelly S, Triplett JD, Pinto MV, Milone M, Diehn FE, Zekeridou A, Liewluck T. Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy. Brain Commun. 2020;2(2):fcaa181. https:\/\/doi.org\/10.1093\/braincomms\/fcaa181.","journal-title":"Brain Commun"},{"issue":"14","key":"1238_CR45","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.3390\/jcm12144769","volume":"12","author":"C Bouchard","year":"2023","unstructured":"Bouchard C, Tremblay JP. Limb-Girdle Muscular Dystrophies Classification and Therapies. J Clin Med. 2023;12(14):4769. https:\/\/doi.org\/10.3390\/jcm12144769.","journal-title":"J Clin Med"},{"key":"1238_CR46","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3389\/fneur.2019.00619","volume":"10","author":"C Strafella","year":"2019","unstructured":"Strafella C, Campoli G, Galota RM, Caputo V, Pagliaroli G, Carboni S, Zampatti S, Peconi C, Mela J, Sancricca C, Primiano G, Minozzi G, Servidei S, Cascella R, Giardina E. Limb-Girdle Muscular Dystrophies (LGMDs): The Clinical Application of NGS Analysis, a Family Case Report. Front Neurol. 2019;10:619. https:\/\/doi.org\/10.3389\/fneur.2019.00619.","journal-title":"Front Neurol"},{"issue":"3","key":"1238_CR47","doi-asserted-by":"publisher","first-page":"130","DOI":"10.36185\/2532-1900-017","volume":"39","author":"C Rodolico","year":"2020","unstructured":"Rodolico C, Bonanno C, Pugliese A, Nicocia G, Benvenga S, Toscano A. Endocrine myopathies: clinical and histopathological features of the major forms. Acta Myol. 2020;39(3):130\u20135. https:\/\/doi.org\/10.36185\/2532-1900-017.","journal-title":"Acta Myol"},{"issue":"1","key":"1238_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13075-019-2093-6","volume":"22","author":"A Meyer","year":"2020","unstructured":"Meyer A, Troyanov Y, Drouin J, Oligny-Longpr\u00e9 G, Landon-Cardinal O, Hoa S, Hervier B, Bourr\u00e9-Tessier J, Mansour AM, Hussein S, Morin V, Rich E, Goulet JR, Chartrand S, Hudson M, Nehme J, Makhzoum JP, Zarka F, Villeneuve E, Raynauld JP, Landry M, O\u2019Ferrall EK, Ferreira J, Ellezam B, Karamchandani J, Larue S, Massie R, Isabelle C, Desch\u00eanes I, Leclair V, Couture H, Targoff IN, Fritzler MJ, Sen\u00e9cal JL. Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients. Arthritis Res Ther. 2020;22(1):5. https:\/\/doi.org\/10.1186\/s13075-019-2093-6.","journal-title":"Arthritis Res Ther"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-026-01238-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-026-01238-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-026-01238-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:02:25Z","timestamp":1791064945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-026-01238-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1238"],"URL":"https:\/\/doi.org\/10.1007\/s11926-026-01238-8","relation":{},"ISSN":["1534-6307"],"issn-type":[{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"assertion":[{"value":"31 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":1,"name":"Ethics","label":"Human and animal rights and informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29"}}